“Scratching the surface” of cutaneous immunity where the microbiome sets the tone and itch turns the volume up

Commensal-driven humoral immunity and itch-scratch neuroimmune responses cooperate to shape microbial homeostasis and host defense in the skin. The skin is not merely a passive physical barrier, but an active immune organ containing innate and adaptive immune cells that interact continuously with the cutaneous microbiome.1 These bidirectional interactions maintain immune homeostasis2; however, shifts toward dysbiosis under stress can lead to skin disorders.2 Research advances in 2025 have significantly expanded our understanding of cutaneous immunity. First, the skin can function as an autonomous lymphoid compartment, capable of mounting localized adaptive immune responses,3, 4 challenging the traditional paradigm that humoral immunity is confined to secondary lymphoid organs, with the skin relying mainly on systemic protection. Second, the itch–scratch axis is being redefined as a biologically defensive neuroimmune circuit rather than a purely pathological reflex.5, 6 Together, these findings support the concept of “anticipatory immunity,” whereby the skin can mount protective responses in preparation for future pathogenic exposure, even in the absence of preceding overt inflammation. Until recently, the contribution of B cells and antibodies at the skin–microbiota interface remained poorly defined, particularly under homeostatic conditions and in the prevention of infection. Gribonika et al. showed that the skin can act as an autonomous lymphoid compartment, forming dermal tertiary lymphoid organs at homeostasis that support skin–microbiota symbiosis and anticipatory immunity. In mice, topical colonization with the human skin commensal S. epidermidis led to two distinct humoral responses. One was the expected induction of conventional germinal center reactions in skin-draining lymph nodes associated with IgG1 and IgG3 antibody responses. The other, more novel response was the development of autonomous lymphoid organs (TLOs) in the skin that locally produced IgG2b and IgG2c. Crucially, the authors demonstrated that this process is enabled by local T cell plasticity, with skin-resident regulatory T cells giving rise to T follicular helper cells that drive local antibody production. Importantly, these dermal structures were functional germinal center-like niches with evidence of class switching, affinity maturation and distinct local clonotypes, suggesting that skin and lymph node humoral responses can follow partly independent trajectories. The autonomous nature of skin TLOs was most clearly demonstrated in splenectomized Lta−/− mice, which lack conventional secondary lymphoid organs, yet still produced local IgG2b and IgG2c antibodies and formed functional cutaneous lymphoid structures in response to S. epidermidis colonization. Moreover, these locally produced antibodies could constrain commensal biomass at the skin surface and protect against subsequent infection, highlighting the skin's ability to mount a protective antibody response independently of professional lymphoid organs. Extending Gribonika's work in a more translational direction, Bousbaine et al. explored whether the commensal-induced antibody response could be molecularly defined and then leveraged for vaccination. After showing that physiologic colonization with S. epidermidis elicited a potent, durable and specific systemic antibody response, the authors combined bacterial genetics, serology and epitope mapping to identify the principal target of this humoral response as accumulation-associated protein (Aap), a large cell-surface adhesin common among S. epidermidis strains. The dominant antibody response predominantly targeted the parallel β-helix and B domains, prompting exploration into engineering Aap to redirect the immune response toward non-native antigens. Using an engineered strain of S. epidermidis expressing tetanus toxin fragment C instead of the parallel β-helix domain of Aap, they showed that simple topical colonization was sufficient to induce high levels of anti-tetanus IgG in serum and IgA at mucosal sites. Moreover, this response protected mice against lethal tetanus toxin challenge, demonstrating that commensal engineering can induce a functional systemic and mucosal antibody response against a non-native immunogen. This was further supported using an Aap–SpyCatcher platform to display recombinant immunogens on the bacterial surface, while passive transfer experiments confirmed that protection was mediated by neutralizing antibodies. Together, these studies substantially expand the concept of anticipatory immunity at the skin barrier: Gribonika et al. showed that commensal colonization can elicit skin-autonomous humoral responses that help preserve host–microbiota symbiosis while protecting against later barrier breach, whereas Bousbaine et al. showed that this pre-emptive antibody program can be molecularly defined and redirected toward needle-free topical vaccination. However, both studies used S. epidermidis, a non-native commensal to mice, so the responses observed may not fully reflect those generated in a natural host setting, despite the authors' efforts to address this. While native murine commensals can also induce systemic antibody responses, their ability to drive comparable local cutaneous immune organization remains unclear. As such, extrapolation to human immunity requires careful interpretation and further investigation. Itch is now recognized as a multifactorial phenomenon arising from complex neuroimmune interactions within the skin. Type 2 cytokines are major drivers of itch and itch-sensitization, particularly in chronic inflammatory conditions like atopic dermatitis.7 While IL-31 has traditionally been regarded as the principal “itch cytokine,” the roles of IL-4 and IL-13 have been less extensively characterized. Jha et al.6 used complementary in vitro and in vivo approaches to define how IL-4 and IL-13, relative to IL-31, shape sensory neurons and the cutaneous inflammatory microenvironment in itch. They found that IL-4 and IL-13 promoted sensory neuron growth in murine and human dorsal root ganglia (DRG) cultures, with comparable or greater effects than IL-31. They further identified a distinct transcriptional signature related to neuronal growth, sensitization and neuroimmune interaction in human DRG cultures stimulated by IL-4 and IL-13. These transcriptomic effects, along with eosinophil-driven neuronal growth in murine DRG, were reversed by IL-4Rα blockade (dupilumab). Together, these findings identify the IL-4/IL-13–IL-4Rα axis as a direct regulator of sensory neuronal growth and neuroimmune crosstalk, rather than simply a downstream inflammatory pathway. Consistent with these in vitro observations, intradermal administration of IL-4, IL-13 and IL-31 into mouse ear pinnae increased intraepidermal nerve fiber density, which is correlated with itch severity in pruritic skin disease. Moreover, IL-4 and IL-13 induced epidermal hyperplasia and infiltration of eosinophils and mast cells. Thus, while IL-4, IL-13 and IL-31 can induce cutaneous nerve fiber growth to a similar degree, IL-4 and IL-13 had additional effects remodeling barrier integrity and the inflammatory microenvironment. This represents a key conceptual advance: IL-31 was not the only type 2 cytokine capable of influencing sensory innervation; IL-4 and IL-13 exerted wider pleiotropic effects on both nerves and surrounding skin tissue. Subsequent behavioral studies demonstrated that IL-13 and IL-31 act as direct acute pruritogens, while IL-4 enhanced IL-13–induced itch. Overall, Jha et al. showed that while IL-4, IL-13 and IL-31 share overlapping pruritogenic effects, IL-4 and IL-13 exert broader effects than IL-31 on sensory nerve architecture, barrier integrity and the inflammatory skin microenvironment, highlighting the IL-4/IL-13–IL-4Rα axis as a central driver of neuroimmune itch pathology. This broader view of itch as an integrated neuroimmune tissue response raises the important question: does itch-induced scratching also serve a functional role in cutaneous defense? Liu et al.5 addressed this by examining cutaneous inflammation and antibacterial host defense. Mice were prevented from scratching through two approaches: genetic ablation of pruriceptive MrgprA3-expressing neurons (Mrgpra3DTR mice) and physical restriction with collars in littermate control mice. Both models experienced reduced ear inflammation in response to a subset of haptens, underscoring the importance of scratching to this inflammatory response. Mechanistically, histological analysis 1 day posthapten challenge showed that edema, neutrophilic infiltration and TNF expression were increased in control mice that could scratch freely but substantially decreased in Mrgpra3DTR mice and collared controls. More importantly, the study showed that itch-sensing and inflammatory-amplification are mediated by distinct neuronal populations: MrgprA3-expressing pruriceptors detect allergic inflammation and drive itch, whereas scratching activates TRPV1-expressing nociceptors to release substance P, which signals through MrgprB2 on mast cells and synergizes with FcεRI-mediated activation to maximize TNF release and neutrophil recruitment. The authors then asked whether this scratch-induced inflammatory program alters the cutaneous microbial environment and benefits the host. Through both 16S rRNA-sequencing and culturomics, scratching was shown to reduce the abundance of viable Staphylococcus, among other cutaneous bacteria. Moreover, in a superficial epicutaneous S. aureus infection model, scratch-induced inflammation reduced bacterial burden by ~10-fold and enhanced host defense, whereas preventing scratching abrogated these protective effects. Thus, these findings illustrate that scratching is not merely pathological: it is a behavioral component of a mast cell-centered neuroimmune circuit that can exacerbate allergic inflammation and enhance antibacterial skin defense. By identifying how the itch–scratch cycle is completed through distinct neuronal and mast cell pathways, the study provides a mechanistic explanation for the paradox that scratching can be both pathogenic and evolutionarily adaptive. In healthy skin, scratching may therefore represent one component of a broader homeostatic defense network that also includes local antibody production, helping to shape microbial community structure at barrier sites. Research in 2025 has significantly advanced our understanding of skin immunology, particularly the interplay between humoral immunity, the cutaneous microbiome and the itch–scratch axis. These studies highlight how the skin harnesses neural architecture, local antibody production and behavioral responses such as scratching to shape its microbial environment and strengthen host defense. Together, these findings support an emerging view of the skin as a more immunologically autonomous and anticipatory tissue than previously appreciated. Moving forward, validation of these mechanisms in human systems will be essential to determine their physiological relevance and therapeutic potential. None. Céline Pattaroni: Conceptualization; writing – review and editing. Aidi Han: Writing – original draft. The authors declare no conflicts of interest.